Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1991 Nov 1;88(21):9638–9642. doi: 10.1073/pnas.88.21.9638

PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.

C L Rosenberg 1, E Wong 1, E M Petty 1, A E Bale 1, Y Tsujimoto 1, N L Harris 1, A Arnold 1
PMCID: PMC52773  PMID: 1682919

Abstract

Rearrangement of the BCL1 (B-cell lymphoma 1) region on chromosome 11q13 appears to be highly characteristic of centrocytic lymphoma and also is found infrequently in other B-cell neoplasms. Rearrangement is thought to deregulate a nearby protooncogene, but transcribed sequences in the immediate vicinity of BCL1 breakpoints had not been identified. PRAD1, previously designated D11S287E, was identified on 11q13 as a chromosomal breakpoint region rearranged with the parathyroid hormone gene in a subset of parathyroid adenomas; this highly conserved putative oncogene, which encodes a novel cyclin, has been linked to BCL1 and implicated also in subsets of breast and squamous cell neoplasms with 11q13 amplification. We report pulsed-field gel electrophoresis data showing BCL1 and PRAD1 to be no more than 130 kilobases apart. PRAD1 mRNA is abundantly expressed in seven of seven centrocytic lymphomas (Kiel classification), in contrast to 13 closely related but noncentrocytic lymphomas. Three of the seven centrocytic lymphomas had detectable BCL1 DNA rearrangement. Also, two unusual cases of CLL with BCL1 rearrangement overexpressed PRAD1, in contrast to five CLL controls. Thus, PRAD1 is an excellent candidate "BCL1 oncogene." Its overexpression may be a key consequence of rearrangement of the BCL1 vicinity in B-cell neoplasms and a unifying pathogenetic feature in centrocytic lymphoma.

Full text

PDF
9638

Images in this article

9639Image
on p.9639
9640Image
on p.9640
9641Image
on p.9641

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnold A., Cossman J., Bakhshi A., Jaffe E. S., Waldmann T. A., Korsmeyer S. J. Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med. 1983 Dec 29;309(26):1593–1599. doi: 10.1056/NEJM198312293092601. [DOI] [PubMed] [Google Scholar]
  2. Arnold A., Kim H. G., Gaz R. D., Eddy R. L., Fukushima Y., Byers M. G., Shows T. B., Kronenberg H. M. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest. 1989 Jun;83(6):2034–2040. doi: 10.1172/JCI114114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arnold A., Staunton C. E., Kim H. G., Gaz R. D., Kronenberg H. M. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med. 1988 Mar 17;318(11):658–662. doi: 10.1056/NEJM198803173181102. [DOI] [PubMed] [Google Scholar]
  4. Bakhshi A., Jensen J. P., Goldman P., Wright J. J., McBride O. W., Epstein A. L., Korsmeyer S. J. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell. 1985 Jul;41(3):899–906. doi: 10.1016/s0092-8674(85)80070-2. [DOI] [PubMed] [Google Scholar]
  5. Cleary M. L., Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci U S A. 1985 Nov;82(21):7439–7443. doi: 10.1073/pnas.82.21.7439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cogliatti S. B., Lennert K., Hansmann M. L., Zwingers T. L. Monocytoid B cell lymphoma: clinical and prognostic features of 21 patients. J Clin Pathol. 1990 Aug;43(8):619–625. doi: 10.1136/jcp.43.8.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cole M. D. The myc oncogene: its role in transformation and differentiation. Annu Rev Genet. 1986;20:361–384. doi: 10.1146/annurev.ge.20.120186.002045. [DOI] [PubMed] [Google Scholar]
  8. Cotter F. E. The role of the bcl-2 gene in lymphoma. Br J Haematol. 1990 Aug;75(4):449–453. doi: 10.1111/j.1365-2141.1990.tb07780.x. [DOI] [PubMed] [Google Scholar]
  9. Croce C. M., Tsujimoto Y., Erikson J., Nowell P. Chromosome translocations and B cell neoplasia. Lab Invest. 1984 Sep;51(3):258–267. [PubMed] [Google Scholar]
  10. Erikson J., Finan J., Tsujimoto Y., Nowell P. C., Croce C. M. The chromosome 14 breakpoint in neoplastic B cells with the t(11;14) translocation involves the immunoglobulin heavy chain locus. Proc Natl Acad Sci U S A. 1984 Jul;81(13):4144–4148. doi: 10.1073/pnas.81.13.4144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  12. Findley H. W., Jr, Cooper M. D., Kim T. H., Alvarado C., Ragab A. H. Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes. Blood. 1982 Dec;60(6):1305–1309. [PubMed] [Google Scholar]
  13. Fukuhara S., Rowley J. D., Variakojis D., Golomb H. M. Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Res. 1979 Aug;39(8):3119–3128. [PubMed] [Google Scholar]
  14. Gonzalez I. L., Gorski J. L., Campen T. J., Dorney D. J., Erickson J. M., Sylvester J. E., Schmickel R. D. Variation among human 28S ribosomal RNA genes. Proc Natl Acad Sci U S A. 1985 Nov;82(22):7666–7670. doi: 10.1073/pnas.82.22.7666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Greaves M., Janossy G. Patterns of gene expression and the cellular origins of human leukaemias. Biochim Biophys Acta. 1978 Oct 27;516(2):193–230. doi: 10.1016/0304-419x(78)90008-2. [DOI] [PubMed] [Google Scholar]
  16. Ince C., Blick M., Lee M., Pathak S., Vadhan-Raj S., Selvanayagam P., Gutterman J. U., Cabanillas F. Bcl-1 gene rearrangements in B cell lymphoma. Leukemia. 1988 Jun;2(6):343–346. [PubMed] [Google Scholar]
  17. Isaacson P. G., Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology. 1987 May;11(5):445–462. doi: 10.1111/j.1365-2559.1987.tb02654.x. [DOI] [PubMed] [Google Scholar]
  18. Jaffe E. S., Bookman M. A., Longo D. L. Lymphocytic lymphoma of intermediate differentiation--mantle zone lymphoma: a distinct subtype of B-cell lymphoma. Hum Pathol. 1987 Sep;18(9):877–880. doi: 10.1016/s0046-8177(87)80262-9. [DOI] [PubMed] [Google Scholar]
  19. Koduru P. R., Offit K., Filippa D. A. Molecular analysis of breaks in BCL-1 proto-oncogene in B-cell lymphomas with abnormalities of 11q13. Oncogene. 1989 Jul;4(7):929–934. [PubMed] [Google Scholar]
  20. Lammie G. A., Fantl V., Smith R., Schuuring E., Brookes S., Michalides R., Dickson C., Arnold A., Peters G. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene. 1991 Mar;6(3):439–444. [PubMed] [Google Scholar]
  21. Lardelli P., Bookman M. A., Sundeen J., Longo D. L., Jaffe E. S. Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol. 1990 Aug;14(8):752–763. doi: 10.1097/00000478-199008000-00007. [DOI] [PubMed] [Google Scholar]
  22. Matsushime H., Roussel M. F., Ashmun R. A., Sherr C. J. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell. 1991 May 17;65(4):701–713. doi: 10.1016/0092-8674(91)90101-4. [DOI] [PubMed] [Google Scholar]
  23. Medeiros L. J., Van Krieken J. H., Jaffe E. S., Raffeld M. Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation. Blood. 1990 Nov 15;76(10):2086–2090. [PubMed] [Google Scholar]
  24. Meeker T. C., Grimaldi J. C., O'Rourke R., Louie E., Juliusson G., Einhorn S. An additional breakpoint region in the BCL-1 locus associated with the t(11;14)(q13;q32) translocation of B-lymphocytic malignancy. Blood. 1989 Oct;74(5):1801–1806. [PubMed] [Google Scholar]
  25. Melo J. V., Brito-Babapulle V., Foroni L., Robinson D. S., Luzzatto L., Catovsky D. Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement. Int J Cancer. 1986 Oct 15;38(4):531–538. doi: 10.1002/ijc.2910380413. [DOI] [PubMed] [Google Scholar]
  26. Motokura T., Bloom T., Kim H. G., Jüppner H., Ruderman J. V., Kronenberg H. M., Arnold A. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 1991 Apr 11;350(6318):512–515. doi: 10.1038/350512a0. [DOI] [PubMed] [Google Scholar]
  27. North G. Starting and stopping. Nature. 1991 Jun 20;351(6328):604–605. doi: 10.1038/351604a0. [DOI] [PubMed] [Google Scholar]
  28. Nowell P., Shankey T. V., Finan J., Guerry D., Besa E. Proliferation, differentiation, and cytogenetics of chronic leukemic B lymphocytes cultured with mitomycin-treated normal cells. Blood. 1981 Mar;57(3):444–451. [PubMed] [Google Scholar]
  29. Ohno H., Doi S., Fukuhara S., Nishikori M., Uchino H., Fujii H. A newly established human lymphoma cell line, FL-18, carrying a 14;18 translocation. Jpn J Cancer Res. 1985 Jul;76(7):563–566. [PubMed] [Google Scholar]
  31. Paquette R. L., Berenson J., Lichtenstein A., McCormick F., Koeffler H. P. Oncogenes in multiple myeloma: point mutation of N-ras. Oncogene. 1990 Nov;5(11):1659–1663. [PubMed] [Google Scholar]
  32. Raffeld M., Jaffe E. S. bcl-1, t(11;14), and mantle cell-derived lymphomas. Blood. 1991 Jul 15;78(2):259–263. [PubMed] [Google Scholar]
  33. Rechavi G., Katzir N., Brok-Simoni F., Holtzman F., Mandel M., Gurfinkel N., Givol D., Ben-Bassat I., Ramot B. A search for bcl1, bcl2, and c-myc oncogene rearrangements in chronic lymphocytic leukemia. Leukemia. 1989 Jan;3(1):57–60. [PubMed] [Google Scholar]
  34. Rimokh R., Berger F., Cornillet P., Wahbi K., Rouault J. P., Ffrench M., Bryon P. A., Gadoux M., Gentilhomme O., Germain D. Break in the BCL1 locus is closely associated with intermediate lymphocytic lymphoma subtype. Genes Chromosomes Cancer. 1990 Sep;2(3):223–226. doi: 10.1002/gcc.2870020310. [DOI] [PubMed] [Google Scholar]
  35. Rosenberg C. L., Kim H. G., Shows T. B., Kronenberg H. M., Arnold A. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene. 1991 Mar;6(3):449–453. [PubMed] [Google Scholar]
  36. Selvanayagam P., Strong L. C., Saunders G. F., Barlogie B. A rare BclI RFLP in the putative oncogene bcl-1 locus. Nucleic Acids Res. 1990 Mar 25;18(6):1665–1665. doi: 10.1093/nar/18.6.1665-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sheibani K., Burke J. S., Swartz W. G., Nademanee A., Winberg C. D. Monocytoid B-cell lymphoma. Clinicopathologic study of 21 cases of a unique type of low-grade lymphoma. Cancer. 1988 Oct 15;62(8):1531–1538. doi: 10.1002/1097-0142(19881015)62:8<1531::aid-cncr2820620814>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  38. Tolksdorf G., Stein H., Lennert K. Morphological and immunological definition of a malignant lymphoma derived from germinal-centre cells with cleaved nuclei (centrocytes). Br J Cancer. 1980 Feb;41(2):168–182. doi: 10.1038/bjc.1980.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Tsujimoto Y., Finger L. R., Yunis J., Nowell P. C., Croce C. M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 1984 Nov 30;226(4678):1097–1099. doi: 10.1126/science.6093263. [DOI] [PubMed] [Google Scholar]
  40. Tsujimoto Y., Jaffe E., Cossman J., Gorham J., Nowell P. C., Croce C. M. Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature. 1985 May 23;315(6017):340–343. doi: 10.1038/315340a0. [DOI] [PubMed] [Google Scholar]
  41. Tsujimoto Y., Yunis J., Onorato-Showe L., Erikson J., Nowell P. C., Croce C. M. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science. 1984 Jun 29;224(4656):1403–1406. doi: 10.1126/science.6610211. [DOI] [PubMed] [Google Scholar]
  42. Van den Berghe H., Vermaelen K., Louwagie A., Criel A., Mecucci C., Vaerman J. P. High incidence of chromosome abnormalities in IgG3 myeloma. Cancer Genet Cytogenet. 1984 Apr;11(4):381–387. doi: 10.1016/0165-4608(84)90017-7. [DOI] [PubMed] [Google Scholar]
  43. Weisenburger D. D., Sanger W. G., Armitage J. O., Purtilo D. T. Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings. Blood. 1987 Jun;69(6):1617–1621. [PubMed] [Google Scholar]
  44. Williams M. E., Meeker T. C., Swerdlow S. H. Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes. Blood. 1991 Jul 15;78(2):493–498. [PubMed] [Google Scholar]
  45. Williams M. E., Westermann C. D., Swerdlow S. H. Genotypic characterization of centrocytic lymphoma: frequent rearrangement of the chromosome 11 bcl-1 locus. Blood. 1990 Oct 1;76(7):1387–1391. [PubMed] [Google Scholar]
  46. Xiong Y., Connolly T., Futcher B., Beach D. Human D-type cyclin. Cell. 1991 May 17;65(4):691–699. doi: 10.1016/0092-8674(91)90100-d. [DOI] [PubMed] [Google Scholar]
  47. Yunis J. J., Oken M. M., Theologides A., Howe R. B., Kaplan M. E. Recurrent chromosomal defects are found in most patients with non-Hodgkin's-lymphoma. Cancer Genet Cytogenet. 1984 Sep;13(1):17–28. doi: 10.1016/0165-4608(84)90084-0. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES